CBNT logo

C-Bond Systems, Inc. (CBNT)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist C-Bond Systems, Inc. (CBNT) ein Basic Materials-Unternehmen mit einer Bewertung von 0. Bewertet mit 47/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 17. März 2026
47/100 KI-Bewertung

C-Bond Systems, Inc. (CBNT) Werkstoff- & Rohstoffexposure

CEOScott R. Silverman
Mitarbeiter20
HauptsitzSan Antonio, US
IPO-Jahr2009

C-Bond Systems, Inc. operates in the specialty chemicals sector, providing nanotechnology-based glass strengthening solutions. Their patented C-Bond technology targets the automotive and architectural glass markets, offering enhanced safety and performance. The company distinguishes itself through its focus on nanotechnology applications within the glass enhancement industry.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

C-Bond Systems presents a focused investment opportunity within the specialty chemicals sector, leveraging its patented nanotechnology to enhance glass strength and performance. With a market capitalization of $0.00B and a P/E ratio of 0.05, the company exhibits potential for growth, driven by increasing demand for safety and performance enhancements in automotive and architectural glass. A gross margin of 52.5% and a profit margin of 76.2% indicate efficient operations. Key catalysts include expanding distribution networks and increasing adoption of C-Bond technology in various transportation and building applications. Potential risks include competition from established chemical companies and the need for continuous innovation to maintain a competitive edge.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Profit Margin of 76.2% indicates strong profitability in its niche market.
  • Gross Margin of 52.5% reflects efficient cost management in production.
  • Beta of 0.32 suggests lower volatility compared to the overall market.
  • Patented C-Bond technology provides a competitive advantage in glass strengthening solutions.
  • Diverse market applications across automotive, architectural, and transportation sectors offer growth opportunities.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Patented nanotechnology solutions.
  • High profit margin.
  • Diverse market applications.
  • Established distribution network.

Schwaechen

  • Small market capitalization.
  • Limited brand recognition.
  • Dependence on patented technology.
  • OTC market listing.

Katalysatoren

  • Ongoing: Expansion of the distribution network for C-Bond NanoShield in the automotive aftermarket.
  • Ongoing: Increasing adoption of C-Bond Secure in architectural glass applications.
  • Ongoing: Leveraging the C-Bond BRS ballistic-resistant film system in security applications.
  • Ongoing: Distribution of MB-10 and Vimoba disinfectant tablets to school facilities and transportation providers.
  • Upcoming: Potential partnerships with international distributors to expand geographic reach.

Risiken

  • Potential: Competition from established chemical companies with greater resources.
  • Potential: Technological obsolescence of C-Bond technology.
  • Potential: Economic downturn affecting demand for automotive and architectural products.
  • Ongoing: Regulatory changes impacting the use of glass strengthening solutions.
  • Ongoing: Risks associated with OTC market listing, including limited liquidity and disclosure.

Wachstumschancen

  • Growth opportunity 1: Expanding the distribution network for C-Bond NanoShield in the automotive aftermarket presents a significant growth opportunity. The market for windshield repair and replacement is substantial, with increasing demand for advanced solutions that enhance safety and durability. By partnering with dealerships and service providers, C-Bond Systems can increase market penetration and drive revenue growth. The timeline for expansion is immediate, with ongoing efforts to establish new distribution channels.
  • Growth opportunity 2: Increasing adoption of C-Bond Secure in architectural glass applications offers a pathway to growth. The demand for stronger and more secure building materials is rising, driven by safety concerns and regulatory requirements. By targeting commercial and residential construction projects, C-Bond Systems can capitalize on this trend and expand its market share. The timeline for adoption is medium-term, as building projects typically have longer planning and construction cycles.
  • Growth opportunity 3: Leveraging the C-Bond BRS ballistic-resistant film system in security applications presents a specialized growth opportunity. The market for ballistic-resistant glass is driven by increasing security threats and the need for enhanced protection in schools, government buildings, and commercial facilities. By focusing on this niche market, C-Bond Systems can command premium pricing and establish a strong competitive position. The timeline for market penetration is medium-term, as security projects often require extensive testing and certification.
  • Growth opportunity 4: Expanding the distribution of MB-10 and Vimoba disinfectant tablets to school facilities and transportation providers represents a diversification opportunity. The demand for effective disinfection solutions remains high, driven by health concerns and regulatory requirements. By leveraging its existing distribution network, C-Bond Systems can generate additional revenue and expand its customer base. The timeline for expansion is immediate, with ongoing efforts to secure new contracts and partnerships.
  • Growth opportunity 5: Exploring international markets for C-Bond technology offers a long-term growth opportunity. The demand for glass strengthening and performance enhancement is global, with significant potential in emerging markets. By establishing partnerships with international distributors and adapting its products to local requirements, C-Bond Systems can expand its geographic reach and diversify its revenue streams. The timeline for international expansion is long-term, as it requires extensive market research and regulatory compliance.

Chancen

  • Expanding distribution network.
  • Increasing adoption in architectural applications.
  • Leveraging ballistic-resistant film system.
  • Exploring international markets.

Risiken

  • Competition from established chemical companies.
  • Technological obsolescence.
  • Economic downturn.
  • Regulatory changes.

Wettbewerbsvorteile

  • Patented C-Bond nanotechnology provides a competitive advantage.
  • Established distribution network in the automotive and architectural sectors.
  • Focus on niche markets with specialized solutions.

Ueber CBNT

Founded in 2013, C-Bond Systems, Inc. is a nanotechnology company focused on developing, manufacturing, and selling patented C-Bond technology in the United States. The company's core offerings include C-Bond NanoShield, designed to strengthen windshield glass and improve hydrophobic properties; C-Bond Secure, a non-toxic solution for enhancing the strength of architectural glass and window film performance; and C-Bond BRS, a ballistic-resistant film system that increases glass structural integrity. In addition to these products, C-Bond Systems also distributes MB-10 and Vimoba disinfectant tablets. The company serves a diverse range of markets, including transportation detailing, automotive, trucking, RV, rental agencies, service vehicles, mass transit, golf carts, aviation, train, and marine. Headquartered in San Antonio, Texas, C-Bond Systems is committed to providing innovative solutions that improve the safety and performance of glass through nanotechnology.

Was das Unternehmen tut

  • Develops patented C-Bond nanotechnology.
  • Manufactures glass strengthening solutions.
  • Sells C-Bond NanoShield for windshields.
  • Offers C-Bond Secure for architectural glass.
  • Provides C-Bond BRS ballistic-resistant film systems.
  • Distributes MB-10 and Vimoba disinfectant tablets.

Geschaeftsmodell

  • Direct sales of C-Bond products to automotive and architectural customers.
  • Distribution agreements with dealerships, service providers, and construction companies.
  • Sales of disinfectant tablets to schools and transportation providers.

Branchenkontext

C-Bond Systems operates within the specialty chemicals industry, which is characterized by innovation and the development of niche solutions. The market for glass strengthening and performance enhancement is driven by increasing safety regulations and consumer demand for improved durability. The competitive landscape includes companies like BUSC, GBGD, GPHBF, HYDI, and HYPF, which offer alternative glass treatment solutions. C-Bond Systems differentiates itself through its patented nanotechnology and focus on specific applications within the automotive and architectural sectors.

Wichtige Kunden

  • Automotive dealerships and service centers.
  • Architectural glass manufacturers and installers.
  • School districts and transportation companies.
KI-Zuversicht: 71% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

C-Bond Systems, Inc. (CBNT) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer CBNT verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CBNT.

Kursziele

Wall-Street-Kurszielanalyse fuer CBNT.

MoonshotScore

47/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von CBNT auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Scott R. Silverman

CEO

Scott R. Silverman serves as the CEO of C-Bond Systems, Inc. His background includes experience in managing and growing technology-driven companies. He is responsible for overseeing the company's strategic direction, product development, and market expansion. His leadership is focused on driving innovation and increasing shareholder value through the commercialization of C-Bond technology.

Erfolgsbilanz: Under Scott R. Silverman's leadership, C-Bond Systems has focused on expanding its product line and distribution network. Key achievements include securing patents for C-Bond technology and establishing partnerships with automotive and architectural customers. His strategic decisions have aimed at increasing market penetration and driving revenue growth.

CBNT OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that C-Bond Systems may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may be subject to greater risks due to less stringent regulatory oversight compared to companies listed on major exchanges like NYSE or NASDAQ. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other stocks.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: As an OTC Other stock, CBNT may experience limited trading volume and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at desired prices. Investors should be aware of the potential for price volatility and illiquidity when trading CBNT.
OTC-Risikofaktoren:
  • Limited financial disclosure.
  • Potential for price volatility.
  • Illiquidity.
  • Less stringent regulatory oversight.
  • Higher risk of fraud or manipulation.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements.
  • Research the company's management team.
  • Assess the company's competitive position.
  • Evaluate the company's growth prospects.
  • Understand the risks associated with OTC trading.
  • Consult with a financial advisor.
  • Check for any regulatory actions or legal issues.
Legitimitaetssignale:
  • Patented C-Bond technology.
  • Established distribution network.
  • Positive profit margin.
  • Focus on niche markets.
  • CEO with relevant experience.

Was Anleger ueber C-Bond Systems, Inc. (CBNT) wissen wollen

What are the key factors to evaluate for CBNT?

C-Bond Systems, Inc. (CBNT) currently holds an AI score of 47/100, indicating low score. Key strength: Patented nanotechnology solutions.. Primary risk to monitor: Potential: Competition from established chemical companies with greater resources.. This is not financial advice.

How frequently does CBNT data refresh on this page?

CBNT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CBNT's recent stock price performance?

Recent price movement in C-Bond Systems, Inc. (CBNT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Patented nanotechnology solutions.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CBNT overvalued or undervalued right now?

Determining whether C-Bond Systems, Inc. (CBNT) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CBNT?

Before investing in C-Bond Systems, Inc. (CBNT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CBNT to a portfolio?

Potential reasons to consider C-Bond Systems, Inc. (CBNT) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Patented nanotechnology solutions.. Additionally: High profit margin.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of CBNT?

Yes, most major brokerages offer fractional shares of C-Bond Systems, Inc. (CBNT) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track CBNT's earnings and financial reports?

C-Bond Systems, Inc. (CBNT) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CBNT earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Financial data is based on available information and may be subject to change.
  • AI analysis is pending and may provide additional insights.
Datenquellen

Popular Stocks